Oguzhan Kuru

Dr. Oguzhan Kuru


Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 June 2012 in Archives of Gynecology and Obstetrics
Verified
Journal Article
Closed access
PDF file
OAOzgur Akbayır
Ozgur Akbayır
AEAytul Corbacıoglu Esmer
Aytul Corbacıoglu Esmer
CNCeyhun Numanoglu
Ceyhun Numanoglu
BGB. Pinar Cılesız Goksedef
B. Pinar Cılesız Goksedef
AAAysu Akca
Aysu Akca
OKOguzhan Kuru
Oguzhan Kuru

22 January 2025 in International Journal of Gynecology & Obstetrics
Verified
Journal Article
Closed access
IEIpek Betul Ozcivit Erkan
Ipek Betul Ozcivit Erkan
OKOguzhan Kuru
Oguzhan Kuru
IAIlkin Acar
Ilkin Acar
AOAtakan Mahmut Oztas
Atakan Mahmut Oztas
AGAltay Gezer
Altay Gezer

1 January 2023 in Revista da Associação Médica Brasileira
Verified
Journal Article
Open access
PDF file
BCBehzat Can
Behzat Can
VKVolkan Karataşlı
Volkan Karataşlı
IÇİlKer Çakir
İlKer Çakir
SSSevil Sayhan
Sevil Sayhan
KHKemal Hansu
Kemal Hansu
OKOguzhan Kuru
Oguzhan Kuru
Uterine carcinosarcomas are aggressive, rare biphasic tumors with malignant epithelial and malignant sarcomatous components. The prognostic significance of the presence of extrauterine sarcoma (heterologous component) is controversial. Therefore, the aim of this study was to investigate the effect of heterologous components in uterine carcinosarcomas on disease-free survival, overall survival, and other prognostic factors.

1 June 2016 in Taiwanese Journal of Obstetrics and Gynecology
Verified
Journal Article
Open access
MSMehmet Sakinci
Mehmet Sakinci
CECihangir Mutlu Ercan
Cihangir Mutlu Ercan
SOSafak Olgan
Safak Olgan
HCHakan Coksuer
Hakan Coksuer
KKKazim Emre Karasahin
Kazim Emre Karasahin
OKOguzhan Kuru
Oguzhan Kuru

16 October 2020 in Journal of Obstetrics and Gynaecology
Verified
Journal Article
Closed access
VKVolkan Karataşlı
Volkan Karataşlı
IÇİlker Çakır
İlker Çakır
BCBehzat Can
Behzat Can
SESelçuk Erkılınç
Selçuk Erkılınç
TKTuğba Karadeniz
Tuğba Karadeniz
MSMuzaffer Sancı
Muzaffer Sancı
Surgical treatment of low-grade endometrial stromal sarcoma consists of hysterectomy. The role of oophorectomy is yet to be established. We aimed to examine the effect of preserving the ovaries on the pattern of recurrences in patients with stage I disease. Thirty-four patients with stage I low-grade endometrial stromal sarcoma were retrospectively analysed. Based on ovarian preservation the whole cohort was divided into two groups. Recurrence (liver, lung, groin and bone) was detected in 4 (11.8%) cases. No significant differences in overall survival or disease-free survival (DFS) were observed between the ovarian preservation and bilateral salpingo-oophorectomy (BSO) groups. Subset analysis revealed no significant difference in DFS between the ovarian preservation and BSO groups in the premenopausal arm. And also, the performance of pelvic (n = 2) or para-aortic lymphadenectomy (n = 6) or adjuvant hormonal therapy did not alter DFS significantly. The 5-year DFS rate for the group which received adjuvant radiotherapy was 62.5 and 94.4% for those which did not (p = .014). Preserving the ovaries had no adverse effect on the recurrence of stage I disease.

6 December 2024 in International Journal of Gynecology & Obstetrics
Verified
Journal Article
Closed access
IEIpek Betul Ozcivit Erkan
Ipek Betul Ozcivit Erkan
OKOguzhan Kuru
Oguzhan Kuru
CSCansu Turker Sarıcoban
Cansu Turker Sarıcoban
MWMarwa Wardak
Marwa Wardak
KCKübra Hamzaoğlu Canbolat
Kübra Hamzaoğlu Canbolat
AEAhmet Emre Eskazan
Ahmet Emre Eskazan